It is the softest thing ever
This is due to underreporting of overweight and obesity diagnoses in the Danish registries, and the fact that GLP-1 receptor agonists were not approved for the treatment of obesity until December 2022
What Did the 2025 Semaglutide Dementia Study Find
Moreover, as hypothyroidism can cause weight gain, semaglutides efficacy in weight reduction could be particularly beneficial in hypothyroid patients struggling with obesity or overweight
Semaglutide emerged from Novo Nordisks systematic GLP-1 analogue optimisation programme as the successor to liraglutide , incorporating structural modifications addressing the three principal pharmacokinetic vulnerabilities of native GLP-1: DPP-IV susceptibility at position 8 addressed by Aib8 alpha-aminoisobutyric acid substitution, proteolytic cleavage at position 34 addressed by Arg34Lys substitution, and the short half-life of unmodified GLP-1 analogues addressed by the C18 fatty diacid conjugation providing tighter albumin binding and longer half-life than liraglutides C16 fatty acid, producing the approximately one-week half-life enabling once-weekly subcutaneous administration
Many researchers on the retatrutide dose schedule find that eating 4 to 5 smaller meals works better than 2 to 3 larger ones